Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 11 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Milligan Michael LeeSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 41,250 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 9 Milligan Michael Lee · CIK 0001993953 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,250 Underlying: Common Stock · 41,250 shares Expires 2034-02-14 F7 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged. F6 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Milligan Michael LeeSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 28,675 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 8 Milligan Michael Lee · CIK 0001993953 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,675 Underlying: Common Stock · 28,675 shares Expires 2033-06-23 F7 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged. F5 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date'), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Milligan Michael LeeSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 38,234 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 7 Milligan Michael Lee · CIK 0001993953 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,234 Underlying: Common Stock · 38,234 shares Expires 2033-02-17 F7 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged. F4 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Milligan Michael LeeSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 85,391 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 6 Milligan Michael Lee · CIK 0001993953 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,391 Underlying: Common Stock · 85,391 shares Expires 2032-01-27 F7 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged. F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 20, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Milligan Michael LeeSee Remarks
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 41,250 | Not disclosed Strike: $18.07 | Not disclosed |
DisclosureSEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 5 Milligan Michael Lee · CIK 0001993953 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,250 shares Expires 2034-02-14 F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged. F6 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Milligan Michael LeeSee Remarks
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 28,675 | Not disclosed Strike: $6.36 | Not disclosed |
DisclosureSEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 4 Milligan Michael Lee · CIK 0001993953 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,675 shares Expires 2033-06-23 F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged. F5 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date'), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Milligan Michael LeeSee Remarks
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 38,234 | Not disclosed Strike: $6.51 | Not disclosed |
DisclosureSEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 3 Milligan Michael Lee · CIK 0001993953 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,234 shares Expires 2033-02-17 F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged. F4 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Milligan Michael LeeSee Remarks
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 85,391 | Not disclosed Strike: $4.63 | Not disclosed |
DisclosureSEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 2 Milligan Michael Lee · CIK 0001993953 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 85,391 shares Expires 2032-01-27 F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged. F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 20, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Milligan Michael LeeSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0000950170-25-022325 · ownership.xml · derivative · entry 1 Milligan Michael Lee · CIK 0001993953 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2035-02-13 F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Duncan JasonSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022316 · ownership.xml · derivative · entry 3 Duncan Jason · CIK 0001741553 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2033-12-11 F4 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged. F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Duncan JasonSee Remarks
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 400,000 | Not disclosed Strike: $12.97 | Not disclosed |
DisclosureSEC source: 0000950170-25-022316 · ownership.xml · derivative · entry 2 Duncan Jason · CIK 0001741553 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400,000 shares Expires 2033-12-11 F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged. F2 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Duncan JasonSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0000950170-25-022316 · ownership.xml · derivative · entry 1 Duncan Jason · CIK 0001741553 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2035-02-13 F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
GrantStock Option (Right to Buy) · Derivative | 170,000 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 13 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2034-02-14 F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F8 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
GrantStock Option (Right to Buy) · Derivative | 127,448 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 12 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,448 Underlying: Common Stock · 127,448 shares Expires 2033-06-23 F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F7 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date'), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
GrantStock Option (Right to Buy) · Derivative | 720,084 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 11 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 720,084 Underlying: Common Stock · 720,084 shares Expires 2032-01-27 F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F6 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
GrantStock Option (Right to Buy) · Derivative | 223,034 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 10 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,034 Underlying: Common Stock · 223,034 shares Expires 2031-06-07 F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F5 · derivative.exercise_date: The performance-based stock option becomes exercisable in two tranches upon the achievement of specified stock price milestones. Each tranche shall vest in 24 equal monthly installments measured from the stock price achievement date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
GrantStock Option (Right to Buy) · Derivative | 270,828 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 9 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,828 Underlying: Common Stock · 270,828 shares Expires 2031-06-07 F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F4 · derivative.exercise_date: The option is early exercisable. 1/36th of the shares subject to the option vest on each monthly anniversary measured from June 1, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
GrantStock Option (Right to Buy) · Derivative | 223,034 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 8 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,034 Underlying: Common Stock · 223,034 shares Expires 2031-06-07 F9 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F2 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 170,000 | Not disclosed Strike: $18.07 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 7 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 170,000 shares Expires 2034-02-14 F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F8 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 127,448 | Not disclosed Strike: $6.36 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 6 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 127,448 shares Expires 2033-06-23 F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F7 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date'), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 720,084 | Not disclosed Strike: $4.63 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 5 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 720,084 shares Expires 2032-01-27 F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F6 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 223,034 | Not disclosed Strike: $2.51 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 4 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 223,034 shares Expires 2031-06-07 F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F5 · derivative.exercise_date: The performance-based stock option becomes exercisable in two tranches upon the achievement of specified stock price milestones. Each tranche shall vest in 24 equal monthly installments measured from the stock price achievement date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 270,828 | Not disclosed Strike: $2.51 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 3 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 270,828 shares Expires 2031-06-07 F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F4 · derivative.exercise_date: The option is early exercisable. 1/36th of the shares subject to the option vest on each monthly anniversary measured from June 1, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 223,034 | Not disclosed Strike: $2.51 | Not disclosed |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 2 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 223,034 shares Expires 2031-06-07 F3 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged. F2 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Pinto JoshuaPresident
|
GrantStock Option (Right to Buy) · Derivative | 3,000,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0000950170-25-022319 · ownership.xml · derivative · entry 1 Pinto Joshua · CIK 0001992595 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Stock · 3,000,000 shares Expires 2035-02-13 F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Halawa AlaaDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,571 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022318 · ownership.xml · derivative · entry 4 Halawa Alaa · CIK 0001992622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,571 Underlying: Common Stock · 28,571 shares Expires 2034-06-13 F4 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F2 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged. F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Halawa AlaaDirector
|
GrantStock Option (Right to Buy) · Derivative | 46,455 | Not disclosed Strike: $1.69 | Not disclosed |
DisclosureSEC source: 0000950170-25-022318 · ownership.xml · derivative · entry 3 Halawa Alaa · CIK 0001992622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,455 Underlying: Common Stock · 46,455 shares Expires 2033-09-14 F4 · derivative.exercise_price: Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. F2 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged. F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from September 14, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Halawa AlaaDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 28,571 | Not disclosed Strike: $9.95 | Not disclosed |
DisclosureSEC source: 0000950170-25-022318 · ownership.xml · derivative · entry 2 Halawa Alaa · CIK 0001992622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,571 shares Expires 2034-06-13 F2 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged. F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC |
Halawa AlaaDirector
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 46,455 | Not disclosed Strike: $17.00 | Not disclosed |
DisclosureSEC source: 0000950170-25-022318 · ownership.xml · derivative · entry 1 Halawa Alaa · CIK 0001992622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,455 shares Expires 2023-09-14 F2 · price: On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged. F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from September 14, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. Read SEC document |
| December 27, 2024 Filed Dec 27, 2024 22:01 UTC |
BERNS PAUL LDirector
|
GiftCommon Stock | 133,097 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-24-000555 · form4.xml · nonDerivative · entry 5 BERNS PAUL L · CIK 0001202769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,418,875 F1 · kind: On December 27, 2024, the Reporting Person transferred, for no consideration, 133,097 shares of Common Stock to each of LULU TRUST OF 2024 FBO AB, LULU TRUST OF 2024 FBO OB, and LULU TRUST OF 2024 FBO HB, of which members of the Reporting Person's immediate family are the sole beneficiaries. Read SEC document |
| December 27, 2024 Filed Dec 27, 2024 22:01 UTC |
BERNS PAUL LDirector
|
GiftCommon Stock | 133,097 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-24-000555 · form4.xml · nonDerivative · entry 3 BERNS PAUL L · CIK 0001202769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,551,972 F1 · kind: On December 27, 2024, the Reporting Person transferred, for no consideration, 133,097 shares of Common Stock to each of LULU TRUST OF 2024 FBO AB, LULU TRUST OF 2024 FBO OB, and LULU TRUST OF 2024 FBO HB, of which members of the Reporting Person's immediate family are the sole beneficiaries. Read SEC document |
| December 27, 2024 Filed Dec 27, 2024 22:01 UTC |
BERNS PAUL LDirector
|
GiftCommon Stock | 133,097 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-24-000555 · form4.xml · nonDerivative · entry 1 BERNS PAUL L · CIK 0001202769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,685,069 F1 · kind: On December 27, 2024, the Reporting Person transferred, for no consideration, 133,097 shares of Common Stock to each of LULU TRUST OF 2024 FBO AB, LULU TRUST OF 2024 FBO OB, and LULU TRUST OF 2024 FBO HB, of which members of the Reporting Person's immediate family are the sole beneficiaries. Read SEC document |
| October 18, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,844 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · derivative · entry 12 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,586 Underlying: Common Stock · 7,844 shares Expires 2031-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| October 18, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,205 | $0.00 Strike: $8.79 | $0.00 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · derivative · entry 11 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,205 shares Expires 2030-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| October 18, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
SaleCommon Stock | 14,049 | $17.03 | $239,319.10 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 7 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,100 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 10, 2024. F3 · price: This transaction was executed in multiple trades in prices ranging from $17.00 to $17.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 18, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionCommon Stock | 7,844 | $2.52 | $19,766.88 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 6 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionCommon Stock | 6,205 | $8.79 | $54,541.95 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 5 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,156 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · derivative · entry 10 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,430 Underlying: Common Stock · 2,156 shares Expires 2031-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| October 17, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,800 | $0.00 Strike: $8.79 | $0.00 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · derivative · entry 9 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,205 Underlying: Common Stock · 1,800 shares Expires 2030-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| October 17, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,783 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · derivative · entry 8 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,783 shares Expires 2030-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| October 17, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
SaleCommon Stock | 7,739 | $17.01 | $131,642.71 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 4 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,100 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 10, 2024. F2 · price: This transaction was executed in multiple trades in prices ranging from $17.00 to $17.045, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 17, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionCommon Stock | 2,156 | $2.52 | $5,433.12 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 3 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionCommon Stock | 1,800 | $8.79 | $15,822.00 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 2 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2024 Filed Oct 18, 2024 22:25 UTC |
Fust Matthew KDirector
|
Exercise / conversionCommon Stock | 3,783 | $8.32 | $31,474.56 |
DisclosureSEC source: 0001610717-24-000511 · form4.xml · nonDerivative · entry 1 Fust Matthew K · CIK 0001397266 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 10, 2024 Filed Oct 11, 2024 20:10 UTC |
Lenz Robert A.Head of R&D
|
SaleCommon Stock | 8,260 | $15.09 | $124,602.93 |
DisclosureSEC source: 0001610717-24-000505 · form4.xml · nonDerivative · entry 2 Lenz Robert A. · CIK 0001992908 · Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 314,706 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 12, 2024. F3 · price: This transaction was executed in multiple trades in prices ranging from $15.00 to 15.2435, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 09, 2024 Filed Oct 11, 2024 20:10 UTC |
Lenz Robert A.Head of R&D
|
SaleCommon Stock | 5,563 | $15.01 | $83,507.31 |
DisclosureSEC source: 0001610717-24-000505 · form4.xml · nonDerivative · entry 1 Lenz Robert A. · CIK 0001992908 · Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 322,966 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 12, 2024. F2 · price: This transaction was executed in multiple trades in prices ranging from $15.00 to $15.065, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 18, 2024 Filed Sep 19, 2024 20:35 UTC |
Lenz Robert A.Head of R&D
|
SaleCommon Stock | 10,676 | $12.09 | $129,090.99 |
DisclosureSEC source: 0001610717-24-000490 · form4.xml · nonDerivative · entry 2 Lenz Robert A. · CIK 0001992908 · Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 328,529 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 12, 2024. F3 · price: This transaction was executed in multiple trades in prices ranging from $12.00 to $12.18, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 17, 2024 Filed Sep 19, 2024 20:35 UTC |
Lenz Robert A.Head of R&D
|
SaleCommon Stock | 30,788 | $11.81 | $363,735.59 |
DisclosureSEC source: 0001610717-24-000490 · form4.xml · nonDerivative · entry 1 Lenz Robert A. · CIK 0001992908 · Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 339,205 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on June 12, 2024. F2 · price: This transaction was executed in multiple trades in prices ranging from $11.5985 to $12.08, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 21:22 UTC |
Aurora Daljit SinghChief Strategy Officer
|
GiftStock Option (Right to Buy) · Derivative | 29,737 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001610717-24-000475 · form4.xml · derivative · entry 8 Aurora Daljit Singh · CIK 0001793971 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 29,737 Underlying: Common Stock · 29,737 shares Expires 2033-06-22 F2 · kind: Represents fully vested stock options transferred pursuant to an option transfer agreement dated September 12, 2024 between the Reporting Person and Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. F2 · derivative.exercise_date: Represents fully vested stock options transferred pursuant to an option transfer agreement dated September 12, 2024 between the Reporting Person and Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. F1 · ownership.nature: Shares held by Aurora Family Trust. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 21:22 UTC |
Aurora Daljit SinghChief Strategy Officer
|
GiftStock Option (Right to Buy) · Derivative | 29,737 | $0.00 Strike: $6.36 | $0.00 |
DisclosureSEC source: 0001610717-24-000475 · form4.xml · derivative · entry 7 Aurora Daljit Singh · CIK 0001793971 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,221 Underlying: Common Stock · 29,737 shares Expires 2033-06-22 F2 · kind: Represents fully vested stock options transferred pursuant to an option transfer agreement dated September 12, 2024 between the Reporting Person and Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. F2 · derivative.exercise_date: Represents fully vested stock options transferred pursuant to an option transfer agreement dated September 12, 2024 between the Reporting Person and Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries. F5 · balance_after: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.